{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:49:17Z","timestamp":1790822957538,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,7,31]],"date-time":"2017-07-31T00:00:00Z","timestamp":1501459200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s00204-017-2036-4","type":"journal-article","created":{"date-parts":[[2017,7,31]],"date-time":"2017-07-31T09:10:24Z","timestamp":1501492224000},"page":"383-399","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Customised in vitro model to detect human metabolism-dependent idiosyncratic drug-induced liver injury"],"prefix":"10.1007","volume":"92","author":[{"given":"Laia","family":"Tolosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 V.","family":"Castell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Jos\u00e9","family":"G\u00f3mez-Lech\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Teresa","family":"Donato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,31]]},"reference":[{"issue":"1","key":"2036_CR1","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1527-3466.2007.00006.x","volume":"25","author":"H Ashrafian","year":"2007","unstructured":"Ashrafian H, Horowitz JD, Frenneaux MP (2007) Perhexiline. Cardiovasc Drug Rev 25(1):76\u201397. doi: 10.1111\/j.1527-3466.2007.00006.x","journal-title":"Cardiovasc Drug Rev"},{"issue":"1","key":"2036_CR2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.taap.2013.11.022","volume":"275","author":"FA Atienzar","year":"2014","unstructured":"Atienzar FA, Novik EI, Gerets HH et al (2014) Predictivity of dog co-culture model, primary human hepatocytes and HepG2 cells for the detection of hepatotoxic drugs in humans. Toxicol Appl Pharmacol 275(1):44\u201361. doi: 10.1016\/j.taap.2013.11.022","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"2036_CR3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2133\/dmpk.DMPK-10-RV-089","volume":"26","author":"TA Baillie","year":"2011","unstructured":"Baillie TA, Rettie AE (2011) Role of biotransformation in drug-induced toxicity: influence of intra- and inter-species differences in drug metabolism. Drug Metab Pharmacokinet 26(1):15\u201329","journal-title":"Drug Metab Pharmacokinet"},{"issue":"2","key":"2036_CR4","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/toxsci\/kfw126","volume":"153","author":"AL Ball","year":"2016","unstructured":"Ball AL, Kamalian L, Alfirevic A, Lyon JJ, Chadwick AE (2016) Identification of the additional mitochondrial liabilities of 2-hydroxyflutamide when compared with its parent compound, flutamide in HepG2 Cells. Toxicol Sci 153(2):341\u2013351. doi: 10.1093\/toxsci\/kfw126","journal-title":"Toxicol Sci"},{"issue":"10","key":"2036_CR5","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1097\/01.fpc.0000054129.14659.ef","volume":"13","author":"ML Barclay","year":"2003","unstructured":"Barclay ML, Sawyers SM, Begg EJ et al (2003) Correlation of CYP2D6 genotype with perhexiline phenotypic metabolizer status. Pharmacogenetics 13(10):627\u2013632. doi: 10.1097\/01.fpc.0000054129.14659.ef","journal-title":"Pharmacogenetics"},{"key":"2036_CR6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0091-679X(08)60603-2","volume":"43 Pt A","author":"TC Becker","year":"1994","unstructured":"Becker TC, Noel RJ, Coats WS et al (1994) Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol 43 Pt A:161\u2013189","journal-title":"Methods Cell Biol"},{"issue":"4\u20135","key":"2036_CR7","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0887-2333(99)00069-7","volume":"13","author":"R Bort","year":"1999","unstructured":"Bort R, Castell JV, Pfeifer A, Gomez-Lechon MJ, Mace K (1999) High expression of human CYP2C in immortalized human liver epithelial cells. Toxicol In Vitro 13(4\u20135):633\u2013638","journal-title":"Toxicol In Vitro"},{"issue":"2","key":"2036_CR8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1212\/WNL.46.2.465","volume":"46","author":"AE Bryant 3rd","year":"1996","unstructured":"Bryant AE 3rd, Dreifuss FE (1996) Valproic acid hepatic fatalities. III. US experience since 1986. Neurology 46(2):465\u2013469","journal-title":"Neurology"},{"issue":"15\u201316","key":"2036_CR9","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.drudis.2011.05.007","volume":"16","author":"M Chen","year":"2011","unstructured":"Chen M, Vijay V, Shi Q, Liu Z, Fang H, Tong W (2011) FDA-approved drug labeling for the study of drug-induced liver injury. Drug Discov Today 16(15\u201316):697\u2013703. doi: 10.1016\/j.drudis.2011.05.007","journal-title":"Drug Discov Today"},{"issue":"1","key":"2036_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/01926230590522284","volume":"33","author":"DM Dambach","year":"2005","unstructured":"Dambach DM, Andrews BA, Moulin F (2005) New technologies and screening strategies for hepatotoxicity: use of in vitro models. Toxicol Pathol 33(1):17\u201326. doi: 10.1080\/01926230590522284","journal-title":"Toxicol Pathol"},{"key":"2036_CR11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.toxlet.2016.05.015","volume":"255","author":"MW Braver den","year":"2016","unstructured":"den Braver MW, Zhang Y, Venkataraman H, Vermeulen NP, Commandeur JN (2016) Simulation of interindividual differences in inactivation of reactive para-benzoquinone imine metabolites of diclofenac by glutathione S-transferases in human liver cytosol. Toxicol Lett 255:52\u201362. doi: 10.1016\/j.toxlet.2016.05.015","journal-title":"Toxicol Lett"},{"issue":"3","key":"2036_CR12","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cbi.2009.07.019","volume":"181","author":"MT Donato","year":"2009","unstructured":"Donato MT, Martinez-Romero A, Jimenez N et al (2009) Cytometric analysis for drug-induced steatosis in HepG2 cells. Chem Biol Interact 181(3):417\u2013423. doi: 10.1016\/j.cbi.2009.07.019","journal-title":"Chem Biol Interact"},{"issue":"9","key":"2036_CR13","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1124\/dmd.110.033605","volume":"38","author":"MT Donato","year":"2010","unstructured":"Donato MT, Hallifax D, Picazo L et al (2010) Metabolite formation kinetics and intrinsic clearance of phenacetin, tolbutamide, alprazolam, and midazolam in adenoviral cytochrome P450-transfected HepG2 cells and comparison with hepatocytes and in vivo. Drug Metab Dispos 38(9):1449\u20131455. doi: 10.1124\/dmd.110.033605","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"2036_CR14","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1177\/1087057111427586","volume":"17","author":"MT Donato","year":"2012","unstructured":"Donato MT, Tolosa L, Jimenez N, Castell JV, Gomez-Lechon MJ (2012) High-content imaging technology for the evaluation of drug-induced steatosis using a multiparametric cell-based assay. J Biomol Screen 17(3):394\u2013400. doi: 10.1177\/1087057111427586","journal-title":"J Biomol Screen"},{"issue":"9","key":"2036_CR15","doi-asserted-by":"publisher","first-page":"946","DOI":"10.2174\/13892002113140900002","volume":"14","author":"MT Donato","year":"2013","unstructured":"Donato MT, Jover R, Gomez-Lechon MJ (2013) Hepatic cell lines for drug hepatotoxicity testing: limitations and strategies to upgrade their metabolic competence by gene engineering. Curr Drug Metab 14(9):946\u2013968. doi: 10.2174\/13892002113140900002","journal-title":"Curr Drug Metab"},{"issue":"8","key":"2036_CR16","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/j.tiv.2011.09.015","volume":"25","author":"DM Frederick","year":"2011","unstructured":"Frederick DM, Jacinto EY, Patel NN, Rushmore TH, Tchao R, Harvison PJ (2011) Cytotoxicity of 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione (DCPT) and analogues in wild type and CYP3A4 stably transfected HepG2 cells. Toxicol In Vitro 25(8):2113\u20132119. doi: 10.1016\/j.tiv.2011.09.015","journal-title":"Toxicol In Vitro"},{"issue":"2","key":"2036_CR17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-8278(97)80496-5","volume":"26","author":"B Fromenty","year":"1997","unstructured":"Fromenty B, Pessayre D (1997) Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokines. J Hepatol 26(2):43\u201353","journal-title":"J Hepatol"},{"issue":"2","key":"2036_CR18","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.tiv.2013.10.015","volume":"28","author":"H Garside","year":"2014","unstructured":"Garside H, Marcoe KF, Chesnut-Speelman J et al (2014) Evaluation of the use of imaging parameters for the detection of compound-induced hepatotoxicity in 384-well cultures of HepG2 cells and cryopreserved primary human hepatocytes. Toxicol In Vitro 28(2):171\u2013181. doi: 10.1016\/j.tiv.2013.10.015","journal-title":"Toxicol In Vitro"},{"issue":"4","key":"2036_CR19","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/FPC.0b013e32835ea0b2","volume":"23","author":"Y Ghodke-Puranik","year":"2013","unstructured":"Ghodke-Puranik Y, Thorn CF, Lamba JK et al (2013) Valproic acid pathway: pharmacokinetics and pharmacodynamics. Pharmacogenet Genom 23(4):236\u2013241. doi: 10.1097\/FPC.0b013e32835ea0b2","journal-title":"Pharmacogenet Genom"},{"issue":"35","key":"2036_CR20","doi-asserted-by":"crossref","first-page":"25129","DOI":"10.1016\/S0021-9258(19)74015-0","volume":"267","author":"AM Gomez-Foix","year":"1992","unstructured":"Gomez-Foix AM, Coats WS, Baque S, Alam T, Gerard RD, Newgard CB (1992) Adenovirus-mediated transfer of the muscle glycogen phosphorylase gene into hepatocytes confers altered regulation of glycogen metabolism. J Biol Chem 267(35):25129\u201325134","journal-title":"J Biol Chem"},{"issue":"1","key":"2036_CR21","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cbi.2006.10.013","volume":"168","author":"MJ Gomez-Lechon","year":"2007","unstructured":"Gomez-Lechon MJ, Castell JV, Donato MT (2007) Hepatocytes\u2013the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo. Chem Biol Interact 168(1):30\u201350. doi: 10.1016\/j.cbi.2006.10.013","journal-title":"Chem Biol Interact"},{"issue":"11","key":"2036_CR22","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1517\/17425255.2014.967680","volume":"10","author":"MJ Gomez-Lechon","year":"2014","unstructured":"Gomez-Lechon MJ, Tolosa L, Conde I, Donato MT (2014) Competency of different cell models to predict human hepatotoxic drugs. Expert Opin Drug Metab Toxicol 10(11):1553\u20131568. doi: 10.1517\/17425255.2014.967680","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"2","key":"2036_CR23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1080\/17425255.2017.1238459","volume":"13","author":"MJ Gomez-Lechon","year":"2017","unstructured":"Gomez-Lechon MJ, Tolosa L, Donato MT (2017) Upgrading HepG2 cells with adenoviral vectors that encode drug-metabolizing enzymes: application for drug hepatotoxicity testing. Expert Opin Drug Metab Toxicol 13(2):137\u2013148. doi: 10.1080\/17425255.2017.1238459","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"3","key":"2036_CR24","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.tox.2009.08.007","volume":"268","author":"ML Greer","year":"2010","unstructured":"Greer ML, Barber J, Eakins J, Kenna JG (2010) Cell based approaches for evaluation of drug-induced liver injury. Toxicology 268(3):125\u2013131. doi: 10.1016\/j.tox.2009.08.007","journal-title":"Toxicology"},{"issue":"1","key":"2036_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2133\/dmpk.DMPK-10-RV-062","volume":"26","author":"FP Guengerich","year":"2011","unstructured":"Guengerich FP (2011) Mechanisms of drug toxicity and relevance to pharmaceutical development. Drug Metab Pharmacokinet 26(1):3\u201314. doi: 10.2133\/dmpk.DMPK-10-RV-062","journal-title":"Drug Metab Pharmacokinet"},{"issue":"1","key":"2036_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/toxsci\/kft223","volume":"137","author":"F Gustafsson","year":"2014","unstructured":"Gustafsson F, Foster AJ, Sarda S, Bridgland-Taylor MH, Kenna JG (2014) A correlation between the in vitro drug toxicity of drugs to cell lines that express human P450s and their propensity to cause liver injury in humans. Toxicol Sci 137(1):189\u2013211. doi: 10.1093\/toxsci\/kft223","journal-title":"Toxicol Sci"},{"issue":"2","key":"2036_CR27","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1093\/toxsci\/kfq154","volume":"116","author":"T Hashizume","year":"2010","unstructured":"Hashizume T, Yoshitomi S, Asahi S et al (2010) Advantages of human hepatocyte-derived transformants expressing a series of human cytochrome p450 isoforms for genotoxicity examination. Toxicol Sci 116(2):488\u2013497. doi: 10.1093\/toxsci\/kfq154","journal-title":"Toxicol Sci"},{"issue":"2\u20133","key":"2036_CR28","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.cbi.2009.01.010","volume":"179","author":"SL Kabler","year":"2009","unstructured":"Kabler SL, Seidel A, Jacob J, Doehmer J, Morrow CS, Townsend AJ (2009) Differential protection by human glutathione S-transferase P1 against cytotoxicity of benzo[a]pyrene, dibenzo[a, l]pyrene, or their dihydrodiol metabolites, in bi-transgenic cell lines that co-express rat versus human cytochrome P4501A1. Chem Biol Interact 179(2\u20133):240\u2013246","journal-title":"Chem Biol Interact"},{"issue":"7","key":"2036_CR29","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1124\/dmd.108.020370","volume":"36","author":"P Kang","year":"2008","unstructured":"Kang P, Dalvie D, Smith E, Zhou S, Deese A, Nieman JA (2008) Bioactivation of flutamide metabolites by human liver microsomes. Drug Metab Dispos 36(7):1425\u20131437. doi: 10.1124\/dmd.108.020370","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"2036_CR30","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.taap.2009.05.007","volume":"238","author":"R Kashimshetty","year":"2009","unstructured":"Kashimshetty R, Desai VG, Kale VM et al (2009) Underlying mitochondrial dysfunction triggers flutamide-induced oxidative liver injury in a mouse model of idiosyncratic drug toxicity. Toxicol Appl Pharmacol 238(2):150\u2013159. doi: 10.1016\/j.taap.2009.05.007","journal-title":"Toxicol Appl Pharmacol"},{"key":"2036_CR31","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1038\/ncomms4739","volume":"5","author":"SJ Kwon","year":"2014","unstructured":"Kwon SJ, Lee DW, Shah DA et al (2014) High-throughput and combinatorial gene expression on a chip for metabolism-induced toxicology screening. Nat Commun 5:3739. doi: 10.1038\/ncomms4739","journal-title":"Nat Commun"},{"issue":"4","key":"2036_CR32","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1016\/j.tiv.2012.08.001","volume":"27","author":"A Lahoz","year":"2013","unstructured":"Lahoz A, Vila MR, Fabre M et al (2013) An in vitro tool to assess cytochrome P450 drug biotransformation-dependent cytotoxicity in engineered HepG2 cells generated by using adenoviral vectors. Toxicol In Vitro 27(4):1410\u20131415. doi: 10.1016\/j.tiv.2012.08.001","journal-title":"Toxicol In Vitro"},{"key":"2036_CR33","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.freeradbiomed.2013.07.038","volume":"65","author":"KK Lee","year":"2013","unstructured":"Lee KK, Fujimoto K, Zhang C et al (2013) Isoniazid-induced cell death is precipitated by underlying mitochondrial complex I dysfunction in mouse hepatocytes. Free Radic Biol Med 65:584\u2013594. doi: 10.1016\/j.freeradbiomed.2013.07.038","journal-title":"Free Radic Biol Med"},{"key":"2036_CR34","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ebcr.2015.08.006","volume":"4","author":"A Nagy","year":"2015","unstructured":"Nagy A, Budi T, Temesvari M, Szever Z, Szabo PT, Monostory K (2015) Adverse events in a newborn on valproate therapy due to loss-of-function mutations in CYP2C9. Epilepsy Behav Case Rep 4:86\u201387. doi: 10.1016\/j.ebcr.2015.08.006","journal-title":"Epilepsy Behav Case Rep"},{"issue":"1\u20133","key":"2036_CR35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.toxlet.2008.10.009","volume":"183","author":"T Nishiya","year":"2008","unstructured":"Nishiya T, Kato M, Suzuki T et al (2008) Involvement of cytochrome P450-mediated metabolism in tienilic acid hepatotoxicity in rats. Toxicol Lett 183(1\u20133):81\u201389. doi: 10.1016\/j.toxlet.2008.10.009","journal-title":"Toxicol Lett"},{"issue":"3","key":"2036_CR36","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.taap.2010.08.007","volume":"248","author":"T Okuda","year":"2010","unstructured":"Okuda T, Norioka M, Shitara Y, Horie T (2010) Multiple mechanisms underlying troglitazone-induced mitochondrial permeability transition. Toxicol Appl Pharmacol 248(3):242\u2013248. doi: 10.1016\/j.taap.2010.08.007","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"2036_CR37","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1006\/rtph.2000.1399","volume":"32","author":"H Olson","year":"2000","unstructured":"Olson H, Betton G, Robinson D et al (2000) Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul Toxicol Pharmacol 32(1):56\u201367. doi: 10.1006\/rtph.2000.1399","journal-title":"Regul Toxicol Pharmacol"},{"issue":"12","key":"2036_CR38","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-137-12-200212170-00007","volume":"137","author":"G Ostapowicz","year":"2002","unstructured":"Ostapowicz G, Fontana RJ, Schiodt FV et al (2002) Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 137(12):947\u2013954","journal-title":"Ann Intern Med"},{"issue":"1\u20132","key":"2036_CR39","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cbi.2010.09.011","volume":"192","author":"BK Park","year":"2011","unstructured":"Park BK, Laverty H, Srivastava A, Antoine DJ, Naisbitt D, Williams DP (2011) Drug bioactivation and protein adduct formation in the pathogenesis of drug-induced toxicity. Chem Biol Interact 192(1\u20132):30\u201336. doi: 10.1016\/j.cbi.2010.09.011","journal-title":"Chem Biol Interact"},{"issue":"6","key":"2036_CR40","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/j.tiv.2008.05.009","volume":"22","author":"MA Robin","year":"2008","unstructured":"Robin MA, Descatoire V, Pessayre D, Berson A (2008) Steatohepatitis-inducing drugs trigger cytokeratin cross-links in hepatocytes. Possible contribution to Mallory-Denk body formation. Toxicol In Vitro 22(6):1511\u20131519. doi: 10.1016\/j.tiv.2008.05.009","journal-title":"Toxicol In Vitro"},{"issue":"1","key":"2036_CR41","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/toxsci\/57.1.177","volume":"57","author":"AP Rolo","year":"2000","unstructured":"Rolo AP, Oliveira PJ, Moreno AJ, Palmeira CM (2000) Bile acids affect liver mitochondrial bioenergetics: possible relevance for cholestasis therapy. Toxicol Sci 57(1):177\u2013185","journal-title":"Toxicol Sci"},{"key":"2036_CR42","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/978-3-642-00663-0_7","volume":"196","author":"A Srivastava","year":"2010","unstructured":"Srivastava A, Maggs JL, Antoine DJ, Williams DP, Smith DA, Park BK (2010) Role of reactive metabolites in drug-induced hepatotoxicity. Handb Exp Pharmacol 196:165\u2013194. doi: 10.1007\/978-3-642-00663-0_7","journal-title":"Handb Exp Pharmacol"},{"issue":"4","key":"2036_CR43","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2174\/1389200033489398","volume":"4","author":"W Tang","year":"2003","unstructured":"Tang W (2003) The metabolism of diclofenac\u2013enzymology and toxicology perspectives. Curr Drug Metab 4(4):319\u2013329","journal-title":"Curr Drug Metab"},{"issue":"8","key":"2036_CR44","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1021\/tx300091x","volume":"25","author":"RA Thompson","year":"2012","unstructured":"Thompson RA, Isin EM, Li Y et al (2012) In vitro approach to assess the potential for risk of idiosyncratic adverse reactions caused by candidate drugs. Chem Res Toxicol 25(8):1616\u20131632. doi: 10.1021\/tx300091x","journal-title":"Chem Res Toxicol"},{"issue":"8","key":"2036_CR45","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.tiv.2011.11.008","volume":"26","author":"L Tolosa","year":"2012","unstructured":"Tolosa L, Donato MT, Perez-Cataldo G, Castell JV, Gomez-Lechon MJ (2012a) Upgrading cytochrome P450 activity in HepG2 cells co-transfected with adenoviral vectors for drug hepatotoxicity assessment. Toxicol In Vitro 26(8):1272\u20131277. doi: 10.1016\/j.tiv.2011.11.008","journal-title":"Toxicol In Vitro"},{"issue":"1","key":"2036_CR46","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/toxsci\/kfs083","volume":"127","author":"L Tolosa","year":"2012","unstructured":"Tolosa L, Pinto S, Donato MT et al (2012b) Development of a multiparametric cell-based protocol to screen and classify the hepatotoxicity potential of drugs. Toxicol Sci 127(1):187\u2013198. doi: 10.1093\/toxsci\/kfs083","journal-title":"Toxicol Sci"},{"issue":"6","key":"2036_CR47","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s00204-013-1012-x","volume":"87","author":"L Tolosa","year":"2013","unstructured":"Tolosa L, Gomez-Lechon MJ, Perez-Cataldo G, Castell JV, Donato MT (2013) HepG2 cells simultaneously expressing five P450 enzymes for the screening of hepatotoxicity: identification of bioactivable drugs and the potential mechanism of toxicity involved. Arch Toxicol 87(6):1115\u20131127. doi: 10.1007\/s00204-013-1012-x","journal-title":"Arch Toxicol"},{"issue":"10","key":"2036_CR48","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1007\/s00204-014-1334-3","volume":"89","author":"L Tolosa","year":"2015","unstructured":"Tolosa L, Carmona A, Castell JV, Gomez-Lechon MJ, Donato MT (2015) High-content screening of drug-induced mitochondrial impairment in hepatic cells: effects of statins. Arch Toxicol 89(10):1847\u20131860. doi: 10.1007\/s00204-014-1334-3","journal-title":"Arch Toxicol"},{"issue":"2\u20133","key":"2036_CR49","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.tox.2005.08.003","volume":"216","author":"L Vignati","year":"2005","unstructured":"Vignati L, Turlizzi E, Monaci S, Grossi P, Kanter R, Monshouwer M (2005) An in vitro approach to detect metabolite toxicity due to CYP3A4-dependent bioactivation of xenobiotics. Toxicology 216(2\u20133):154\u2013167. doi: 10.1016\/j.tox.2005.08.003","journal-title":"Toxicology"},{"issue":"4","key":"2036_CR50","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/10408440590935620","volume":"35","author":"JL Walgren","year":"2005","unstructured":"Walgren JL, Mitchell MD, Thompson DC (2005) Role of metabolism in drug-induced idiosyncratic hepatotoxicity. Crit Rev Toxicol 35(4):325\u2013361","journal-title":"Crit Rev Toxicol"},{"issue":"1","key":"2036_CR51","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cbi.2004.09.011","volume":"150","author":"JJ Xu","year":"2004","unstructured":"Xu JJ, Diaz D, O\u2019Brien PJ (2004) Applications of cytotoxicity assays and pre-lethal mechanistic assays for assessment of human hepatotoxicity potential. Chem Biol Interact 150(1):115\u2013128","journal-title":"Chem Biol Interact"},{"issue":"1","key":"2036_CR52","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/toxsci\/kfn109","volume":"105","author":"JJ Xu","year":"2008","unstructured":"Xu JJ, Henstock PV, Dunn MC, Smith AR, Chabot JR, de Graaf D (2008) Cellular imaging predictions of clinical drug-induced liver injury. Toxicol Sci 105(1):97\u2013105. doi: 10.1093\/toxsci\/kfn109","journal-title":"Toxicol Sci"},{"key":"2036_CR53","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cbi.2015.10.009","volume":"255","author":"J Xuan","year":"2016","unstructured":"Xuan J, Chen S, Ning B, Tolleson WH, Guo L (2016) Development of HepG2-derived cells expressing cytochrome P450s for assessing metabolism-associated drug-induced liver toxicity. Chem Biol Interact 255:63\u201373. doi: 10.1016\/j.cbi.2015.10.009","journal-title":"Chem Biol Interact"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00204-017-2036-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-017-2036-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-017-2036-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T16:44:53Z","timestamp":1659285893000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00204-017-2036-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,31]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["2036"],"URL":"https:\/\/doi.org\/10.1007\/s00204-017-2036-4","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,31]]}}}